000999 Stock Overview
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥44.00 |
| 52 Week High | CN¥52.55 |
| 52 Week Low | CN¥36.24 |
| Beta | 0.43 |
| 1 Month Change | 1.95% |
| 3 Month Change | -9.95% |
| 1 Year Change | 1.94% |
| 3 Year Change | 44.52% |
| 5 Year Change | 73.91% |
| Change since IPO | 319.38% |
Recent News & Updates
Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Trading At A 39% Discount?
Jan 03
Little Excitement Around China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Nov 18Recent updates
Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Trading At A 39% Discount?
Jan 03Little Excitement Around China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Nov 18Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results
Aug 26Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?
Aug 09Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Jul 12China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50
Jun 09China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 23An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued
Apr 16Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Mar 20Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?
Feb 28Shareholder Returns
| 000999 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.5% | 0.8% | 1.9% |
| 1Y | 1.9% | 3.4% | 17.4% |
Return vs Industry: 000999 underperformed the CN Pharmaceuticals industry which returned 4.5% over the past year.
Return vs Market: 000999 underperformed the CN Market which returned 18.1% over the past year.
Price Volatility
| 000999 volatility | |
|---|---|
| 000999 Average Weekly Movement | 3.5% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.7% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 000999 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000999's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 20,318 | n/a | www.999.com.cn |
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injections; formula granules; and anti-infective drugs.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Fundamentals Summary
| 000999 fundamental statistics | |
|---|---|
| Market cap | CN¥56.51b |
| Earnings (TTM) | CN¥3.41b |
| Revenue (TTM) | CN¥25.87b |
16.6x
P/E Ratio2.2x
P/S RatioIs 000999 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000999 income statement (TTM) | |
|---|---|
| Revenue | CN¥25.87b |
| Cost of Revenue | CN¥12.10b |
| Gross Profit | CN¥13.78b |
| Other Expenses | CN¥10.36b |
| Earnings | CN¥3.41b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 13, 2025
| Earnings per share (EPS) | 2.66 |
| Gross Margin | 53.24% |
| Net Profit Margin | 13.18% |
| Debt/Equity Ratio | 10.0% |
How did 000999 perform over the long term?
See historical performance and comparisonDividends
4.5%
Current Dividend Yield81%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 03:56 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is covered by 41 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Changming He | BOCI Research Ltd. |
| Jessica Li | BofA Global Research |
| Shuchang Liu | Changjiang Securities Co. LTD. |